Jiutian Chemical Group Limited (C8R.SI) Jumps 4.3% on Pre-Market Momentum

Jiutian Chemical Group Limited (C8R.SI) surged 4.3% to S$0.024 in pre-market trading on the Singapore Exchange (SES), marking a modest recovery from recent weakness. The chemical manufacturer, which produces dimethylformamide, methylamine, and sodium hydrosulfite for industrial applications across China, continues to face significant operational headwinds. Despite the intraday bounce, C8R.SI stock remains under pressure from persistent losses and deteriorating fundamentals. Meyka AI’s real-time market analysis platform tracks this volatile micro-cap stock as it navigates challenging market conditions.

C8R.SI Stock Price Movement and Technical Position

C8R.SI stock trades at S$0.024, up 0.001 from the previous close of S$0.023. The stock trades above its 50-day average of S$0.0226 and below its 200-day average of S$0.025285, signaling mixed technical positioning. Volume remains subdued at 500,000 shares, representing just 16.8% of the average daily volume of 2.98 million shares. The year-to-date decline of 4% reflects broader sector weakness in basic materials. Year-high stands at S$0.032, while year-low sits at S$0.018, showing the stock’s compressed trading range over the past twelve months.

Financial Metrics Reveal Deep Operational Stress

Jiutian Chemical Group’s financial picture deteriorates across multiple dimensions. The company reports a negative EPS of -S$0.02 with a PE ratio of -1.2, indicating ongoing losses. Revenue per share stands at just S$0.0534, while net income per share is -S$0.083, reflecting severe profitability challenges. The price-to-sales ratio of 2.29 appears elevated given the negative earnings backdrop. Free cash flow per share is -S$0.078, signaling cash burn rather than generation. Market capitalization sits at S$47.7 million, making C8R.SI a micro-cap stock with limited liquidity and institutional interest.

Meyka AI Grade and Fundamental Deterioration

Meyka AI rates C8R.SI with a grade of C+, suggesting a “Hold” recommendation based on comprehensive analysis. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The company’s return on equity stands at -30.9%, while return on assets is -23.6%, both deeply negative. Debt-to-equity ratio of 0.28 remains manageable, but the company’s inability to generate profits makes leverage metrics less relevant. Revenue declined 56.4% year-over-year, while operating cash flow fell 59.2%, indicating structural business deterioration. These grades are not guaranteed and Meyka is not a financial advisor.

Price Forecast and Long-Term Outlook

Meyka AI’s forecast model projects C8R.SI stock reaching S$0.027 within one year, implying 12.5% upside from current levels. The three-year forecast stands at S$0.031, while the five-year projection reaches S$0.035. However, these forecasts assume operational stabilization that remains uncertain given current trends. Track C8R.SI on Meyka for real-time updates and technical signals. The stock’s technical indicators show CCI at -117.76 (oversold), while RSI sits at 46.98, suggesting neither extreme weakness nor strength. Williams %R at -100 indicates potential bounce potential, though fundamental recovery remains the critical catalyst.

Final Thoughts

Jiutian Chemical Group Limited’s 4.3% pre-market surge reflects short-term technical positioning rather than fundamental improvement. The company faces severe operational challenges, including collapsing revenues, negative earnings, and deteriorating cash flows. While C8R.SI stock trades below book value at a 0.54 price-to-book ratio, this discount reflects genuine distress rather than opportunity. Investors should await evidence of operational stabilization before considering positions in this micro-cap chemical manufacturer. The next earnings announcement on August 12, 2026, will be critical for assessing whether management can reverse current trends.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.